24/7 Patient Assistance: 760-405-8205

Edmund K. Moon, MD

Pulmonologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Diffuse Pleural Thickening Laryngeal Cancer Pleural Effusions Pleural Mesothelioma Pleural Plaques

specialties & services

  • Bio & Insurance Information

    Dr. Edmund Moon got his medical degree from University of Maryland and residency from Temple University Hospital. After a short period of time he earned his fellowship from University of Pennsylvania Health System. He is certified in pulmonary disease and internal medicine and has been in practice for 20 years. Dr. Moon is affiliated with several hospitals including University of Pennsylvania Cancer Center and Penn Presbyterian Medical Center.



  • Education & Training

    dept_icon

    University of Maryland

    Medical School

    dept_icon

    Temple University Hospital

    Residency

    dept_icon

    University of Pennsylvania Health System

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Critical Care Medicine

    American Board of Internal Medicine - Pulmonary Disease

  • Hospital & Practice

    Abramson Cancer Center Hospital University of Pennsylvania (HUP)

    Languages: English/Spanish

    (800) 789-7366

    University of Pennsylvania, 3400 Civic Center Blvd

    Philadelphia, Pennsylvania 19104

    Read More

    Penn Presbyterian Medical Center

    Languages: English/Spanish

    (215) 662-8000

    51 N 39th St

    Philadelphia, Pennsylvania 19104

    Read More
  • Publications & Memberships

    Dr. Edmund K. Moon has contributed to 2 publications.

    Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.

    Sterman, D. H.,Alley, E.,Stevenson, J. P.,Friedberg, J.,Metzger, S.,Recio, A.,Moon, E. K.,Haas, A. R.,Vachani, A.,Katz, S. I.,Sun, J.,Heitjan, D.,Hwang, W. T.,Litzky, ...; Clin. Cancer Res.. 2016 Mar 13.

    See more >>

    Multifactorial T cell Hypofunction That is Reversible Can Limit the Efficacy of Chimeric Antibody Receptor-transduced Human T cells in Solid Tumors

    Moon, E. K.,Wang, L. C.,Dolfi, D. V.,Wilson, C. B.,Ranganathan, R.,Sun, J.,Kapoor, V.,Scholler, J.,Pure, E.,Milone, M. C.,June, C. H.,Riley, J.,Wherry, E. J.,Albelda, ...; Clin. Cancer Res.. 2014 Jun 13.

    See more >>